Table 5 Statistical analysis of epilepsy patient’s adherence towards treatment using multiple linear cox regression analysis
Risk factors | Cox Regression Analysis | ||
|---|---|---|---|
Controla/Casesb | ORc | CId (95%) | |
Age | 2.04 | (1.61-2.58) | |
Patients with migraine | |||
Yes | 310/687 | 2.21 | (1.79-2.74) |
No | 5331/2910 | 1.00 | |
Psychiatric disorders | |||
Yes | 137/999 | 4.28 | (3.63-4.93) |
No | 5504/2598 | 1.00 | |
Patients with other comorbidities | |||
Yes | 207/586 | 1.52 | (1.29-1.75) |
No | 5434/3011 | 1.00 | |
Class of drugs | |||
Levetiracetam | 2042/1224 | 0.69 | (0.55-0.86) |
Valproic acid | 1158/452 | 0.52 | (0.46-0.58) |
Carbamazepine | 745/564 | 0.81 | (0.69-0.96) |
Lamotrigine | 780/305 | 0.80 | (0.68-0.95) |
Lacosamide | 614/310 | 0.65 | (0.51-0.82) |
Others | 299/743 | 2.35 | (1.93-2.88) |